Published in Pharmacol Rev on March 01, 1966
Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg (1974) 4.48
Effects of catecholamines and adenosine derivatives given into the brain of fowls. Br J Pharmacol (1972) 1.23
Alterations in cyclic AMP metabolism in human bronchial asthma. 3. Leukocyte and lymphocyte responses to steroids. J Clin Invest (1973) 1.12
Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest (1979) 1.06
Effect of adenosine 3',5'-monophosphate on production of glucose and ammonia by renal cortex. J Clin Invest (1969) 1.02
Thyrotoxic muscle disease. Postgrad Med J (1968) 1.02
Stimulation of anterior pituitary adenyl cyclase activity and adenosine 3':5'-cyclic phosphate by hypothalamic extract and prostaglandin E1. Proc Natl Acad Sci U S A (1969) 0.95
An in vitro effect of triiodothyronine on rat adipose tissue. J Clin Invest (1967) 0.94
An adrenergic control system in Tetrahymena. Proc Natl Acad Sci U S A (1967) 0.88
Influence of thyroid hormones on the sensitivity of cardiac and smooth muscle to biogenic amines and other drugs. Br J Pharmacol (1970) 0.88
The possible involvement of Na+ ions in corticosterone-induced hypercontractility in the rat anococcygeus muscle. Br J Pharmacol (1976) 0.86
Biochemistry of hyperthyroidism and hypothyroidism. Postgrad Med J (1968) 0.84
Significance of the caffeine-like effect of various purines, pyrimidines and derivatives on adipose-tissue phosphodiesterase. Biochem J (1971) 0.84
The effect of lipolytic hormones and theophylline on heat production in brown adipose tissue in vivo. Br J Pharmacol Chemother (1967) 0.84
Pertussis sensitization as an animal model for the abnormal bronchial sensitivity of asthma. Yale J Biol Med (1968) 0.80
Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine. J Clin Invest (1979) 0.80
Thyroid and adrenal relationships. Postgrad Med J (1968) 0.78
Tissue variability and some properties of the accumulation of [3H]-corticosterone by isolated organs [proceedings]. Br J Pharmacol (1977) 0.75
The effect of thyroid hormones on the action of some centrally acting drugs. Br J Pharmacol (1970) 0.75
A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05
Enzymatic breakage and joining of deoxyribonucleic acid. VI. Further purification and properties of polynucleotide ligase from Escherichia coli infected with bacteriophage T4. J Biol Chem (1968) 7.09
Oxidative metabolism of naphthalene by soil pseudomonads. The ring-fission mechanism. Biochem J (1964) 6.19
Enzymatic breakage and joining of deoxyribonucleic acid, I. Repair of single-strand breaks in DNA by an enzyme system from Escherichia coli infected with T4 bacteriophage. Proc Natl Acad Sci U S A (1967) 5.98
Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol (1986) 5.32
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Bacterial metabolism of 2,4-dichlorophenoxyacetate. Biochem J (1971) 5.11
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet (1997) 4.95
Transient accumulation of Okazaki fragments as a result of uracil incorporation into nascent DNA. Proc Natl Acad Sci U S A (1977) 4.83
Enzymatic breakage and joining of deoxyribonucleic acid. V. End group labeling and analysis of deoxyribonucleic acid containing single straned breaks. J Biol Chem (1968) 4.65
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Stimulation of intestinal adenyl cyclase by cholera toxin. Nature (1971) 4.27
soxR, a locus governing a superoxide response regulon in Escherichia coli K-12. J Bacteriol (1990) 4.26
TB policy and the badger culling trials. Vet Rec (2006) 4.14
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
TB policy and the badger culling trials. Vet Rec (2006) 3.84
Two divergently transcribed genes, soxR and soxS, control a superoxide response regulon of Escherichia coli. J Bacteriol (1991) 3.81
Mutants of Escherichia coli with altered deoxyribonucleases. I. Isolation and characterization of mutants for exonuclease 3. J Mol Biol (1972) 3.65
Exonuclease III of Escherichia coli K-12, an AP endonuclease. Methods Enzymol (1980) 3.50
Endonuclease IV of Escherichia coli is induced by paraquat. Proc Natl Acad Sci U S A (1987) 3.20
Effects of a concurrent task on fixed-interval responding in humans. J Exp Anal Behav (1963) 3.05
Genetic mapping of xthA, the structural gene for exonuclease III in Escherichia coli K-12. J Bacteriol (1976) 3.01
Specific mutator effects of ung (uracil-DNA glycosylase) mutations in Escherichia coli. J Bacteriol (1982) 2.92
Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol Pharmacol (1977) 2.90
Mutations simultaneously affecting endonuclease II and exonuclease III in Escherichia coli. Proc Natl Acad Sci U S A (1975) 2.89
Drowning mortality in Los Angeles County, 1976 to 1984. JAMA (1988) 2.89
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med (2008) 2.85
Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther (1966) 2.75
Endonuclease III (nth) mutants of Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.72
Two-stage induction of the soxRS (superoxide response) regulon of Escherichia coli. J Bacteriol (1992) 2.71
Further observations on overt "mediating" behavior and the discrimination of time. J Exp Anal Behav (1969) 2.64
Effects of psychotherapy with children and adolescents revisited: a meta-analysis of treatment outcome studies. Psychol Bull (1995) 2.59
Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol (1998) 2.58
A computer analysis of serial interactions in spaced responding. J Exp Anal Behav (1966) 2.34
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31
Endonuclease II of Escherichia coli is exonuclease III. J Biol Chem (1976) 2.27
Role of exonuclease III in the base excision repair of uracil-containing DNA. J Bacteriol (1982) 2.23
Mass screening for mutants with altered DNases by microassay techniques. Methods Enzymol (1974) 2.18
Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. J Consult Clin Psychol (1995) 2.17
Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther (1979) 2.15
Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass. Heart (2009) 2.12
Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. Adv Cyclic Nucleotide Res (1978) 2.12
The lab versus the clinic. Effects of child and adolescent psychotherapy. Am Psychol (1992) 2.11
Beta-receptor activity in aorta; variations with age and species. Circ Res (1970) 2.06
Escherichia coli mutants deficient in deoxyuridine triphosphatase. J Bacteriol (1978) 2.02
Pharmacological regulation of calmodulin. Ann N Y Acad Sci (1980) 2.02
TB policy and the ISG's findings. Vet Rec (2007) 2.02
Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. Mol Pharmacol (1976) 2.02
The 5'-terminal dinucleotides of the separated strands of T7 bacteriophage deoxyribonucleic acid. J Mol Biol (1967) 2.01
Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A (1971) 2.00
Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98
SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form. Proc Natl Acad Sci U S A (1996) 1.94
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J Bacteriol (1988) 1.89
Behavioral responses to artificial food colors. Science (1980) 1.82
Regulation of the soxRS oxidative stress regulon. Reversible oxidation of the Fe-S centers of SoxR in vivo. J Biol Chem (1997) 1.77
Interactions of drugs with adrenergic neurons. Pharmacol Rev (1966) 1.76
A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75
Microassay of adenosine-3',5'-monophosphate (cyclic AMP) in brain and other tissues by the luciferin-luciferase system. J Neurochem (1971) 1.69
Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl (2009) 1.69
Displacement of one drug by another from carrier or receptor sites. Proc R Soc Med (1965) 1.68
Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol (1990) 1.67
Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol (1980) 1.66
Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. Proc Natl Acad Sci U S A (1991) 1.64
Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. Biochim Biophys Acta (1978) 1.59
The development of fixed-ratio performance under the influence of ribonucleic acid. J Exp Anal Behav (1972) 1.58
The microanalysis of fixed-interval responding. J Exp Anal Behav (1983) 1.58
Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg (2004) 1.56
A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Life Sci (1976) 1.56
Influence of drugs on behavior controlled by internal and external stimuli. J Pharmacol Exp Ther (1966) 1.56
The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther (1969) 1.55
Commercial talc and talcosis. Arch Environ Health (1967) 1.51
Familial contexts of adolescent ego development. Child Dev (1984) 1.48
Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J Pharmacol Exp Ther (1982) 1.47
Resistance to vecuronium in patients with cerebral palsy. Anesth Analg (1991) 1.44
Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. Biochem Pharmacol (1982) 1.43
Ezymatic breakage and joining of deoxyribonucleic acid. VII. Properties of the enzyme-adenylate intermediate in the polynucleotide ligase reaction. J Biol Chem (1968) 1.42
Effectiveness of psychotherapy with children and adolescents: a meta-analysis for clinicians. J Consult Clin Psychol (1987) 1.42
Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones. Br J Pharmacol (1968) 1.38
Gametocytogenesis by malaria parasites in continuous culture. Nature (1980) 1.38
Giving up on child psychotherapy: who drops out? J Consult Clin Psychol (1987) 1.37
Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther (1987) 1.37
Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet (2009) 1.36
Overproduction and physical characterization of SoxR, a [2Fe-2S] protein that governs an oxidative response regulon in Escherichia coli. J Biol Chem (1995) 1.36
Oligonucleotide mapping studies of standard and defective Sindbis virus RNA. J Virol (1979) 1.36
Studies on the joining of DNA by polynucleotide ligase of phage T4. Cold Spring Harb Symp Quant Biol (1968) 1.35
Mutants of Escherichia coli with altered deoxyribonucleases. II. Isolation and characterization of mutants for exonuclease I. J Mol Biol (1974) 1.35
Parent reports of behavioral and emotional problems among children in Kenya, Thailand, and the United States. Child Dev (1993) 1.34
A microanalysis of drug effects on fixed-ratio performance in pigeons. J Pharmacol Exp Ther (1972) 1.33
Human Observing Behavior after Signal Detection. J Exp Anal Behav (1960) 1.33
Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol Sci (1988) 1.32
A study of conidiation in Neurospora crassa. J Gen Microbiol (1966) 1.31
Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation. J Pharmacol Exp Ther (1967) 1.30
The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther (1966) 1.30
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
dfp Gene of Escherichia coli K-12, a locus affecting DNA synthesis, codes for a flavoprotein. J Bacteriol (1985) 1.29